I
Amsterdam-based early-stage venture capital firm backing technology and life sciences companies, primarily at Series A, with a long-term, hands-on approach.
Innogest Capital
Early-stage venture capital firm taking direct equity stakes in technology and healthcare companies, working with founders to build scalable businesses, from offices in Milan, Turin, Geneva and San Francisco.
Innogest Capital is an early-stage venture capital firm that takes direct equity stakes in technology and healthcare companies. It works alongside entrepreneurial teams as operating partners rather than passive capital providers, supporting portfolio companies in building scalable businesses, attracting talent and pursuing international opportunities. The firm describes a long-term investor orientation, with an emphasis on innovation intended to have measurable impact.
Sector focus spans deep technology, digital and tech platforms and scalable platform businesses, together with healthcare and life sciences. Within healthcare, areas of interest include cardiovascular disease, neurological disorders and oncology. The stated ambition across the portfolio is global reach rather than domestic scale alone.
Innogest Capital operates from Milan and Turin in Italy, Geneva in Switzerland and San Francisco in the United States - a network that connects the firm to European and US innovation hubs. Further detail on fund size, team composition and founding date is not disclosed in the information available here.
Open jobs
No open jobs right now.